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factors. Multiple regression analysis revealed that hyperten-
sion, dyslipidemia, hyperglycemia and hyperuricemia were 
independently associated with obesity. eGFR decreased 
with a higher number of risk factors. Obesity, blood pres-
sure, dyslipidemia, hyperglycemia and hyperuricemia were 
independently associated with proteinuria.
Conclusion Obesity can pose an independent risk fac-
tor for proteinuria in young adults. Hypertension, dyslipi-
demia, hyperglycemia and hyperuricemia were indepen-
dently associated with obesity. eGFR decreased with a 
higher number of risk factors.
Keywords Obesity · Young adults · Proteinuria ·  
Renal function · Chronic kidney disease
Introduction
Obesity has become a global epidemic and its prevalence 
in adult population is increasing at a rapid pace. Obesity, 
along with hypertension, impaired glucose tolerance or 
diabetes mellitus and dyslipidemia are well-known fac-
tors of metabolic syndrome. Together, they increase the 
risk of cardiovascular disorders and chronic kidney disease 
(CKD). Currently, kidney damages attributed to obesity are 
getting more attention. The morbidity of obesity-related 
glomerulopathy (ORG) increases with obesity. In the USA, 
the morbidity of ORG was 0.2 % in 1986–1990, while it 
increased to about 2 % in 1996–2000 [1]. Therefore, it is 
crucial that renal damage in young obese adults should be 
analyzed at the early stage. The aim of this study was to 
compare the clinical characteristics of obese vs. nonobese 
young adult subjects and to analyze the factors that influ-
ence decreased renal function and proteinuria in young 
obese adults.
Abstract 
Objective To investigate the prevalence of obesity in 
young adults and to analyze the influencing factors on renal 
functions and proteinuria in this population.
Methods This study comprised civil servants between 20 
and 39 years old, who received physical examinations at 
the First Affiliated Hospital of Fujian Medical University. 
The subjects were categorized into four groups based on 
age (20–24, 25–29, 30–34 and 35–39 years) and the num-
ber of risk factors they had (hypertension, dyslipidemia, 
hyperglycemia and hyperuricemia). The relationships 
between obesity and the prevalence of proteinuria, between 
obesity and risk factors and between estimated glomerular 
filtration rate (eGFR) and proteinuria were analyzed.
Results Among the 2293 young civil servants, in men 
the prevalence of obesity was 33.3 % and proteinuria was 
2.5 %. However in women the prevalence of obesity and 
proteinuria was 7.5 % and 1.7 %, respectively. The levels 
of blood pressure, serum uric acid (UA), cholesterol (TC), 
triglyceride (TG), fasting glucose (FBG) and low-density 
lipoprotein cholesterol (LDL-C) were lower and the level 
of serum high-density lipoprotein cholesterol (HDL-C) was 
higher in nonobese groups compared with obese groups. 
There were no significant differences in eGFR between 
the two groups. The eGFR in male subjects was associated 
with age, UA, body mass index (BMI), FBG, TC, TG, LDL 
and HDL, and in female subjects associated with UA, age, 
BMI, diastolic blood pressure, FBG and LDL. BMI in both 
males and females increased with the higher number of risk 
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The subjects were young civil servants between 20 and 
39 years old in Fuzhou City. They received physical exami-
nation at the First Affiliated Hospital of Fujian Medical 
University between November 2008 and August 2009. Sub-
jects who failed to provide data such as routine urine test 
and serum creatinine were excluded from the study. Also, 
of the subjects who received repeated examinations, only 
the first examination results were included.
Measurements
Physical examination
The height, body weight, body mass index (BMI), systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) of 
all subjects were measured according to the unified stand-
ards. The BMI of each subject was calculated by divid-
ing the weight (kg) by the square of the height (m2). The 
blood pressure was measured using an electrical manom-
eter after letting the subjects rest for 15 min. Blood pres-
sure measurement was performed up to three times accord-
ing to JNCVII standard, and the mean value was used for 
statistical analysis. The interval between each measurement 
was 5 min. In case there was a difference of more than 
10 mmHg between two measurements; we chose the two 
closest measurements to calculate the mean value. The sub-
ject’s height was defined as net height measured without 
shoes. Body weight was measured with empty stomach and 
no coat.
Laboratory tests
For laboratory analysis, subjects’ morning urine samples 
were collected. Female subjects who were menstruat-
ing were excluded. Serum creatinine (Scr), urea nitrogen 
(BUN), uric acid (UA), fasting glucose (FBG), total cho-
lesterol (TC), triglycerides (TG), high-density lipoprotein 
cholesterol (HDL-C) and low-density lipoprotein cho-
lesterol (LDL-C) were tested. Urinary protein and occult 
blood were measured by urine dipstick test. Urine red cell 
counting was carried out by an automatic analyzer (uFl00, 
Sysmex, Japan). Proteinuria ≥0.3 g/L was considered 
positive. FBG was detected by hexokinase method with an 
intra-assay coefficient of variation <2.0 % and inter-assay 
coefficient of variation <2.5 %. FBG ≥ 6.1 mmol/L was 
considered abnormal. TC, TG, HDL-C, LDL-C, UA and Scr 
were measured using a full automatic biochemical analyzer 
(Hitachi 7600) with an intra-assay coefficient of variation 
<1.5 % and inter-assay coefficient of variation <2.5 %.
Diagnostic code
Estimated glomerular filtration rate (eGFR) was calculated 
using the equation of MDRD as follows: 186 × Scr(mg/dl) 
^ (−1.154) × age ^ (−0.203), including a correction factor 
of 0.742 for women [2]. 1 µmol Scr = 0.0113 mg/dl.
The diagnosis of metabolic syndrome (Chinese Diabe-
tes Society, 2004) (1) Overweight or obesity was defined 
as BMI ≥ 25.0 kg/m2. (2) Dyslipidemia was defined as 
TG ≥ 1.70 mmol/L and/or HDL-C < 0.9 mmol/L (men) 
and  < 1.0 mmol/L (women). (3) Hypertension was defined 
as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg, includ-
ing those who had been diagnosed with hypertension and 
had received treatment. (4) Hyperglycemia was defined 
as FBG ≥ 6.1 mmol/L and 2 h postprandial blood glu-
cose ≥ 11.1 mmol/L, and/or those who had been diagnosed with 
diabetes. (5) Hyperuricemia was defined as UA ≥ 420 μmol/L 
(men) and ≥ 360 μmol/L (women). Based on the number of 
CKD risk factors (dyslipidemia, hypertension, hyperglycemia 
and hyperuricemia), the subjects were classified into group 0 
(no risk factor), group 1 (one risk factor), group 2 (two risk fac-
tors) and group 3 (three or four risk factors).
Statistical analysis
All the data were entered into Excel by two researchers. 
The data were presented as x ± s. Student’s t test was used 
to evaluate differences between the obese and nonobese 
groups. The enumeration data were analyzed by χ2 test. 
Related risk factors that affect renal function were analyzed 
by multivariate regression analysis and stepwise regres-
sion analysis with variables including age, BMI, SBP, DBP, 
Table 1  Characteristics of males and females analyzed
Characteristics Male Female P value
n 1292 1001 –
Age (years) 31.8 ± 5.5 31.3 ± 5.3 0.042
Body mass index (kg/m2) 23.5 ± 3.3 21.1 ± 2.6 0.000
Obesity (%) 33.3 7.5 0.000
Systolic BP (mm Hg) 114.3 ± 13.4 106.7 ± 11.8 0.000
Diastolic BP (mm Hg) 75.7 ± 9.8 69.9 ± 8.7 0.000
Proteinuria ( %) 2.5 1.7 0.000
Serum creatinine (μmol/L) 75.2 ± 9.8 51.7 ± 7.3 0.000
eGFR (ml/min) 113.9 ± 17.8 131.2 ± 21.7 0.000
FBG (mmol/L) 5.0 ± 0.7 4.8 ± 0.4 0.000
TC (mmol/L) 4.88 ± 0.91 4.60 ± 0.82 0.000
TG (mmol/L) 1.54 ± 1.03 0.87 ± 0.45 0.000
LDL-C (mmol/L) 2.80 ± 0.76 2.44 ± 0.68 0.000
HDL-C (mmol/L) 1.32 ± 0.28 1.60 ± 0.34 0.000
UA (mmol/L) 383.6 ± 69.3 271.5 ± 51.5 0.000
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FBG, TC, TG, LDL-C, HDL-C and UA. Related risk fac-
tors for proteinuria were analyzed by two classifications of 
non-conditional logistic regression analysis with variables 
including gender, age, BMI, obesity, hypertension, dyslip-
idemia, high FBG and hyperuricemia. All data were ana-
lyzed using SPSS version 11.7.
Results
Subjects’ baseline characteristics and physical 
examination data
A total of 1292 male and 1001 female eligible subjects were 
enrolled in our study. Their baseline characteristics are rep-
resented in Table 1. 33.3 % of male and 7.5 % of female 
subjects were obese. The gender differences in the charac-
teristics of obesity and nonobesity in different age groups 
and in the same age group are shown in Tables 2 and 3. 
The average age was similar between obese and nonobese 
subjects in different age groups. In male subjects of differ-
ent ages, blood pressure, TC, TG and LDL-C were higher, 
while HDL-C level was lower in the obese group com-
pared with the nonobese group. UA in the 25- to 29-year 
age group, 30- to 34-year age group and 35- to 39-year age 
group was higher in the obese group than in the nonobese 
group. FBG in the 30- to 34-year age group and in the 35- 
to 39-year age group was higher in the obese group than 
in the nonobese group. In female subjects, HDL-C in the 
25- to 29-year age group, 30- to 34-year age group and 35- 
to 39-year age group was lower in the obese group than in 
the nonobese group. TG and UA in the 30- to 34-year age 
Table 2  Characteristics of male 
obese and nonobese subjects
Characteristics 20–24 years 25–29 years
Obese Nonobese P value Obese Nonobese P value
N 31 126 – 88 179 –
Age (years) 22.6 ± 1.3 22.3 ± 1.3 0.160 27.1 ± 1.5 26.7 ± 1.4 0.488
Body mass index (kg/m2) 27.1 ± 2.4 20.7 ± 2.1 0.000 27.2 ± 2.3 21.5 ± 2.1 0.000
Systolic BP (mm Hg) 120.6 ± 20.3 114.3 ± 13.4 0.037 115.9 ± 13.2 114.3 ± 12.1 0.312
Diastolic BP (mm Hg) 77.6 ± 11.4 72.8 ± 8.3 0.008 77.3 ± 10.1 73.3 ± 8.8 0.001
Proteinuria (%) 0 4.5 0.000 3.4 2.2 0.572
Serum creatinine (μmol/L) 76.7 ± 10.3 75.0 ± 8.3 0.323 77.7 ± 9.6 75.7 ± 9.0 0.100
eGFR (ml/min) 119.1 ± 19.0 121.9 ± 16.2 0.408 112.7 ± 16.3 116.1 ± 17.0 0.119
FBG (mmol/L) 5.1 ± 0.7 4.9 ± 0.6 0.206 4.9 ± 0.6 4.9 ± 0.4 0.686
TC (mmol/L) 4.73 ± 0.70 4.44 ± 0.78 0.053 5.34 ± 0.93 4.63 ± 0.85 0.000
TG (mmol/L) 1.33 ± 0.68 1.07 ± 0.58 0.038 2.11 ± 1.35 1.24 ± 0.74 0.000
LDL (mmol/L) 2.86 ± 0.59 2.52 ± 0.66 0.011 3.19 ± 0.79 2.57 ± 0.73 0.000
HDL (mmol/L) 1.19 ± 0.17 1.38 ± 0.29 0.002 1.25 ± 0.25 1.37 ± 0.29 0.001
UA (mmol/L) 402.7 ± 79.3 378.9 ± 71.1 0.105 409.2 ± 71.6 371.6 ± 63.8 0.000
Characteristics 30–34 years 35–39 years
Obese Nonobese P value Obese Nonobese P value
N 126 241 – 185 316 –
Age (years) 32.3 ± 1.4 32.1 ± 1.4 0.264 37.1 ± 1.4 37.1 ± 1.4 0.856
Body mass index (kg/m2) 27.1 ± 2.8 21.9 ± 2.0 0.000 27.0 ± 1.6 22.1 ± 1.9 0.000
Systolic BP (mm Hg) 115.1 ± 11.7 112.0 ± 12.0 0.009 118.7 ± 15.0 112.1 ± 13.1 0.000
Diastolic BP (mmHg) 78.3 ± 9.7 73.8 ± 8.9 0.000 81.6 ± 11.3 75.1 ± 9.3 0.000
Proteinuria (%) 4.8 1.2 0.068 4.3 0.6 0.007
Serum creatinine (μmol/L) 75.9 ± 11.1 76.0 ± 9.2 0.831 75.3 ± 10.4 73.2 ± 10.1 0.035
eGFR (ml/min) 112.7 ± 19.0 114.5 ± 15.4 0.515 110.3 ± 17.8 113.8 ± 19.0 0.039
FBG (mmol/L) 5.2 ± 0.7 4.9 ± 0.5 0.000 5.3 ± 1.3 5.0 ± 0.7 0.000
TC (mmol/L) 5.10 ± 1.14 4.82 ± 0.85 0.008 5.23 ± 0.87 4.82 ± 0.82 0.000
TG (mmol/L) 2.03 ± 1.35 1.33 ± 0.94 0.000 2.11 ± 1.21 1.41 ± 0.77 0.000
LDL (mmol/L) 2.97 ± 0.92 2.74 ± 0.72 0.010 3.07 ± 0.74 2.74 ± 0.68 0.000
HDL (mmol/L) 1.22 ± 0.21 1.35 ± 0.27 0.000 1.21 ± 0.23 1.36 ± 0.30 0.000
UA (mmol/L) 402.6 ± 71.0 373.8 ± 66.4 0.000 395.9 ± 69.7 376.1 ± 67.3 0.009
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group and in the 35- to 39-year age group was higher in the 
obese group than in the nonobese group. eGFR was similar 
in male and female subjects of different age groups.
Risk factors of CKD
We evaluated the relationships between CKD risk factors 
and BMI, and between the risk factors and eGFR. The per-
centage of group 0, 1, 2 and 3 in male subjects was 41.6 % 
(n = 538), 37.2 % (n = 481), 16.9 % (n = 218), and 4.3 % 
(n = 55). The corresponding percentage in female subjects 
was 82.6 % (n = 826), 15.4 % (n = 154), 1.7 % (n = 17) 
and 0.4 % (n = 4). The mean ages of the four groups in 
male subjects were 31.4 ± 5.4, 31.7 ± 5.4, 32.8 ± 5.0 
and 33.7 ± 4.7, respectively. The mean ages of the four 
groups in female subjects were 31.2 ± 5.3, 32.0 ± 5.2, 
33.2 ± 4.7 and 36.5 ± 3.3, respectively. There was no 
significant age difference in male and female subjects 
among all four groups (P > 0.05). The mean BMIs of the 
four groups in male subjects were 22.2 ± 3.0, 23.7 ± 3.1, 
25.3 ± 2.9 and 26.7 ± 3.0, respectively. In female subjects, 
the mean BMIs were 20.8 ± 2.4, 22.2 ± 3.0, 23.1 ± 2.7 
and 27.7 ± 3.4, respectively. BMI increased as the number 
of risk factors increased (Fig. 1). Multivariate analysis indi-
cated that these risk factors were independently associated 
with obesity, as shown in Table 4. The eGFRs in the four 
groups were 115.1 ± 17.5, 113.4 ± 17.6, 113.1 ± 17.7 and 
111.0 ± 21.2 ml/min in male subjects, and 131.1 ± 21.2, 
133.3 ± 24.5, 126.3 ± 17.4 and 116.2 ± 17.0 ml/min in 
female subjects, respectively. There was no significant dif-
ference within group (P > 0.05). However, eGFR decreased 
as the number of risk factors increased (Fig. 2).
Table 3  Characteristics of 
female obese and nonobese 
subjects
Characteristics 20–24 years 25–29 years
Obese Nonobese P value Obese Nonobese P value
N 4 118 – 12 242 –
Age (years) 22.3 ± 1.7 22.6 ± 1.3 0.648 27.3 ± 1.4 26.8 ± 1.4 0.198
Body mass index (kg/m2) 27.8 ± 2.0 19.6 ± 1.9 0.000 26.0 ± 0.9 20.3 ± 2.0 0.000
Systolic BP (mm Hg) 108.3 ± 3.6 107.5 ± 11.2 0.895 111.2 ± 10.1 106.1 ± 10.7 0.106
Diastolic BP (mmHg) 70.3 ± 4.6 63.9 ± 7.4 0.724 71.5 ± 8.7 65.0 ± 7.8 0.290
Proteinuria (%) 0 1.6 0.000 8.3 1.2 0.136
Serum creatinine (μmol/L) 53.0 ± 7.0 52.7 ± 6.6 0.929 51.4 ± 6.5 52.4 ± 7.1 0.629
eGFR (ml/min) 134.9 ± 16.8 136.2 ± 20.0 0.898 134.5 ± 19.8 132.6 ± 20.8 0.754
FBG (mmol/L) 5.1 ± 0.2 4.7 ± 0.4 0.034 5.0 ± 0.3 4.7 ± 0.4 0.043
TC (mmol/L) 4.92 ± 0.97 4.43 ± 0.69 0.167 4.29 ± 0.86 4.56 ± 0.87 0.289
TG (mmol/L) 1.26 ± 1.07 0.77 ± 0.30 0.005 1.00 ± 0.36 0.83 ± 0.51 0.283
LDL (mmol/L) 2.89 ± 0.84 2.30 ± 0.51 0.029 2.41 ± 0.75 2.39 ± 0.74 0.930
HDL (mmol/L) 1.35 ± 0.29 1.63 ± 0.34 0.114 1.33 ± 0.29 1.59 ± 0.32 0.008
UA (mmol/L) 310.5 ± 36.0 287.2 ± 45.0 0.309 299.6 ± 48.9 277.5 ± 50.8 0.255
Characteristics 30–34 years 35–39 years
Obese Nonobese P value Obese Nonobese P value
N 16 254 – 43 312 –
Age (years) 32.3 ± 1.2 32.2 ± 1.3 0.698 37.0 ± 1.5 37.0 ± 1.4 0.973
Body mass index (kg/m2) 27.5 ± 2.1 20.6 ± 1.9 0.000 26.9 ± 2.0 21.8 ± 2.5 0.000
Systolic BP (mm Hg) 118.4 ± 19.0 105.8 ± 11.6 0.000 109.8 ± 12.5 106.6 ± 12.4 0.107
Diastolic BP (mmHg) 80.3 ± 11.3 69.5 ± 9.3 0.000 74.0 ± 9.9 70.4 ± 8.6 0.064
Proteinuria (%) 6.3 2.0 0.309 2.3 1.2 0.515
Serum creatinine (μmol/L) 50.1 ± 6.5 50.3 ± 7.1 0.889 51.6 ± 7.6 51.8 ± 7.7 0.904
eGFR (ml/min) 134.3 ± 20.6 134.2 ± 22.3 0.994 127.0 ± 21.8 126.4 ± 21.9 0.931
FBG (mmol/L) 5.0 ± 0.5 4.8 ± 0.4 0.159 4.9 ± 0.5 4.9 ± 0.4 0.724
TC (mmol/L) 5.34 ± 1.44 4.56 ± 0.81 0.000 4.86 ± 0.82 4.70 ± 0.77 0.191
TG (mmol/L) 1.45 ± 0.63 0.84 ± 0.34 0.000 1.23 ± 0.63 0.93 ± 0.45 0.000
LDL (mmol/L) 3.26 ± 1.38 2.38 ± 0.65 0.000 2.70 ± 0.76 2.51 ± 0.62 0.083
HDL (mmol/L) 1.42 ± 0.33 1.60 ± 0.34 0.029 1.45 ± 0.26 1.61 ± 0.35 0.003
UA (mmol/L) 309.6 ± 48.1 260.8 ± 49.6 0.000 299.3 ± 51.1 265.7 ± 53.0 0.000
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Multivariate analysis of eGFR
Multivariate analysis showed that in both male and female 
subjects, eGFR was negatively correlated with age, BMI, 
UA and TC, positively correlated with FBG, HDL-C, 
LDL-C and TG, and not correlated with SBP (Table 5). The 
male and female eGFRs were considered as dependent var-
iables and the age, BMI, DBP, FBG, HDL-C, LDL-C, TC, 
TG and UA were considered as independent variables in 
multiple regression analysis. The analysis indicated that in 
the male group, eGFR was correlated with age, UA, BMI, 
FBG, TC, TG, LDL-C and HDL-C. In the female group, 
eGFR was correlated with UA, age, BMI, DBP, FBG and 
LDL-C (Tables 6, 7).
Proteinuria
The prevalence of proteinuria in male and female subjects 
was 2.5 and 1.7 %, respectively, with no significant differ-
ence between two groups. The univariate odds ratios for 
proteinuria of potential risk factors such as BMI, obesity, 
hypertension, dyslipidemia, high FBG and hyperuricemia 
are shown in Table 8. The multivariate odds ratios for pro-
teinuria of potential risk factors such as obesity, hyperten-
sion, dyslipidemia, high FBG and hyperuricemia are shown 
in Table 9. Univariate analysis and multivariate analysis 
showed that obesity, hypertension, dyslipidemia, high FBG 
and hyperuricemia were independently correlated with pro-
teinuria. Hyperglycemia possesses the highest odds ratios 
for proteinuria. Conversely, increasing age was indepen-










































Fig. 1  a Relationship between male BMI and the number of risk fac-
tors. b Relationship between female BMI and the number of risk fac-
tors
Table 4  Odds ratios of the risk factors and obesity
Odds ratio 95 % CI P value
Gender 0.298 0.225–0.395 <0.001
Age 1.039 1.017–1.062 0.001
High BP 2.200 1.694–2.857 <0.001
Hyperglycemia 2.457 1.300–4.644 0.006
Hyperuricemia 1.901 1.467–2.465 <0.001



















































Fig. 2  a Relationship between male eGFR and the number of risk 
factors. b Relationship between female eGFR and the number of risk 
factors
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Discussion
In 2002, a survey conducted by China National Nutri-
tion and Health showed that Chinese adults’ overweight 
rate was 22.8 %. In our study population, the obesity rate 
of males between 20 and 39 years old was 33.3 % and of 
females 7.5 % with an average of 22.0 % which was com-
parable to the previous finding. Blood pressure, serum uric 
acid, serum lipids and fasting glucose of obese subjects 
were higher than those of nonobese subjects. HDL-C of 
obese subjects was lower than that of nonobese subjects. It 
indicated that obese young adults had higher risk for devel-
oping hypertension, hyperlipidemia, hyperglycemia and 
hyperuricemia than nonobese counterparts. Hypertension, 
hyperlipidemia, hyperglycemia and hyperuricemia are the 
risk factors for CKD. Hypertension has been shown to be 
a significant risk factor for kidney failure in several large 
population-based studies [3–5]. Several cohort studies in 
the USA [6, 7] and Japan [8] have identified hyperlipi-
demia as also a possible risk factor for the development and 
progression of CKD. Diabetes has been considered as an 
initiation risk factor of CKD [9]. Cain et al. [10] found that 
increasing serum uric acid levels were positively associated 
Table 5  Correlation analysis 
of male and female eGFR and 
related variables
Group Age BMI SBP DBP FBG HDL LDL TC TG UA
Male
 r value −0.147 −0.070 0.048 −0.051 0.091 0.058 0.082 −0.100 0.095 −0.124
 P value <0.001 0.012 0.089 0.066 0.001 0.039 0.003 <0.001 0.001 <0.001
Female
 r value −0.145 −0.040 0.016 −0.055 0.057 0.080 0.051 −0.071 0.075 −0.298
 P value <0.001 0.049 0.457 0.009 0.006 <0.001 0.014 0.001 <0.001 <0.001
Table 6  Multiple regression analysis of male eGFR and variables
Variable Partial regression coefficient Standard error of mean Standard partial regression coefficient t value P value
Age −0.441 0.092 −0.132 −4.778 <0.001
UA −0.033 0.007 −0.128 −4.514 <0.001
BMI −0.487 0.175 −0.090 −2.790 0.005
FBG 2.340 0.679 0.095 3.446 0.001
TC −7.014 1.875 −0.395 −3.740 <0.001
TG 2.566 0.739 0.150 3.472 0.001
LDL-C 5.902 1.947 0.252 3.031 0.002
HDL 5.833 2.754 0.092 2.156 0.031
Table 7  Multiple regression analysis of female eGFR and variables
Variable Partial regression coefficient Standard error of mean Standard partial regression coefficient t value P value
Age −0.560 0.079 −0.139 −7.073 <0.001
UA −0.084 0.005 −0.329 −15.568 <0.001
BMI −0.345 0.152 −0.052 −2.272 0.023
DBP −0.121 0.046 −0.055 −2.635 0.008
FBG 1.854 0.683 0.054 2.716 0.007
LDL-C −1.170 0.592 −0.041 −1.976 0.048
Table 8  Univariate odds ratios of the risk factors for proteinuria
Risk factor Odds ratio 95 % CI P value
Gender 0.277 0.122–0.631 0.002
Age 0.977 0.922–1.036 0.442
BMI 1.120 1.034–1.214 0.006
Obesity 2.789 1.470–5.294 0.002
High BP 2.256 1.133–4.494 0.021
Hyperglycemia 13.591 5.897–31.327 <0.001
Hyperuricemia 3.751 1.973–7.131 <0.001
Dyslipidemia 2.781 1.457–5.308 0.002
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with CKD. This association appeared to be independent 
of age, gender, smoking status, alcohol intake, education, 
diabetes mellitus, hypertension, BMI and total cholesterol 
levels. Our study also identified that eGFR decreased as the 
number of the above risk factors increased.
Obesity may be associated with increased risk for CKD 
independent of diabetes and hypertension [11]. For exam-
ple, higher level of proteinuria is a risk factor of CKD 
[9]. Several studies had indicated that obesity was associ-
ated with proteinuria. Chagnac et al. [12] found that non-
diabetic obese patients with normal blood pressure had 
higher albumin excretion rate, higher GFR and glomerular 
transmembrane pressure than normal people. The rise of 
glomerular transmembrane pressure will lead to the rise of 
GRF. The rise of GFR will cause the damage of glomer-
ular filtration membrane and result in the rise of albumin 
excretion [13]. Tran et al. [14] reported a case of a 48-year-
old male patient with severe obesity. When the patient’s 
weight reduced to 118, 110 and 102 kg, respectively, his 
24-h urinary protein excretion reduced to 7.6, 2.1 and 
0.85 g, respectively. The CARDIA study [15] showed that 
an unhealthy lifestyle (unhealthy diet, smoking and obe-
sity) may lead to incident microalbuminuria. But there are 
few studies on the relationship between obesity and pro-
teinuria in youth. In China, such study has not been per-
formed previously. Our study showed that obesity was an 
independent risk factor for proteinuria in youth.
There were some limitations associated with our study. 
First, the subjects might have physiological proteinuria, 
but they had no fever and had been told not to do strenu-
ous exercise before the test, which could decrease the false-
positive rate. Second, we did not test microalbuminuria. 
So, the morbidity of proteinuria might be underestimated 
in our study. Third, the diagnosis of obesity was based on 
the standard of Chinese Diabetes Society. We did not meas-
ure waists and hips. Thus, visceral obesity might be missed, 
which could also decrease the false-positive rate. Fourth, we 
used the equation of MDRD to estimate the glomerular fil-
tration rate (eGFR). The MDRD equation was first proposed 
by the National Kidney Foundation, K/DOQI clinical prac-
tice guidelines for chronic kidney disease: evaluation, clas-
sification, and stratification in 2002 [2]. The MDRD equa-
tion is now widely used in nephrology. But this equation 
has some limitations. For example, creatinine is affected by 
the muscle mass of the subject. So if the subject is too fat 
or too thin, this equation is not accurate enough to estimate 
the GFR. Serum cystatin C has been proposed as a simple, 
accurate and rapid endogenous marker of GFR in research 
and clinical practice. It is more stable than creatinine and 
less influenced by the muscle and gender. One meta-anal-
ysis showed that serum cystatin C was clearly superior to 
serum creatinine as a marker of GFR [16]. So in our further 
study, we may ues cystatin C to estimate GFR.
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